Premium
Serum antibodies from MS patients do not recognize HTLV‐I, HIV‐1, HIV‐2 and SIV
Author(s) -
BROKSTAD KARL ALBERT,
KALLAND KARL HENNING,
HAAHEIM LARS,
PAGE MARK,
NYLAND HARALD
Publication year - 1994
Publication title -
apmis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 88
eISSN - 1600-0463
pISSN - 0903-4641
DOI - 10.1111/j.1699-0463.1994.tb05199.x
Subject(s) - antibody , virology , antigen , hiv antigens , immunology , multiple sclerosis , virus , macaque , group specific antigen , medicine , viral disease , biology , paleontology
A retroviral aetiology has been proposed for multiple sclerosis (MS). Although there is as yet no definitive evidence of viral involvement, there have been preliminary reports of antiretroviral antibody detection in sera from MS patients. Such sera have, for example, been found to react with HTLV‐I. We here describe investigations involving various immunological techniques which attempt to confirm the virus‐specific nature of these antibodies against a range of human and macaque retroviruses. Sera from 25 MS patients, 25 patients with non‐associated neurological diseases and 16 patients with non‐neurological conditions were tested by immunoblotting methods using lysates of HIV‐1‐, HIV‐2‐, HTLV‐I‐ and SIV‐infected cells as antigens. None of the sera reacted against any of these retroviral antigens but each serum demonstrated a distinctive and reproducible reaction pattern against cellular components of the cells in which the viruses were propagated. Further examination of the sera was carried out by ELISA using synthetic oligopeptides covering the HIV‐1 Gag p24 protein as antigens. None of the sera reacted with the peptides. Our results suggest that in some MS patients the repeated seropositivity to HTLV‐I may be due to the reaction with host cell proteins.